 character vitro chemosensit periop human ovarian malign adenosin triphosph chemosensit vitro chemosensit primari recurr human ovarian tumor sampl adenosin triphosph chemosensit sensit equal decreas intracellular adenosin triphosph versu control peak plasma concentr agent assay single-ag dose-respons pattern viabil drug concentr thirteen primari tumor sensit sensit sensit combin seven recurr tumor sensit sensit sensit combin dose-respons characterist vitro sensit rate articl consist report patient respons literatur adenosin triphosph chemosensit assay effici reliabl instrument vitro chemosensit assess human tumor warrant clinic investig